Report Categories
View AllRecent Articles
View All
Oxlcn Stock Analysis Oxford Lane 7.125 2029 Preferred Gains 0.58 Percent To 24.3 20260401
Medicus Pharma MDCX Price Action Q4 2025 Below Expectations
LBRX LB Pharmaceuticals Inc shares jump 96 after Q4 2025 EPS edges past consensus analyst estimates
Why Tonix TNXP looks solid from every angle Smart Money Active 20260508
APGE Apogee Therapeutics Inc posts narrower Q4 2025 loss than estimates shares rise modestly after its latest quarterly earnings release